Umoja Biopharma Appoints Scott Myers as Chairman of its Board of Directors
SEATTLE, Nov. 21, 2024 (GLOBE NEWSWIRE) -- Umoja Biopharma, Inc. (Umoja), the clinical-stage leader of in vivo and off-the-shelf therapies that aim to realize the full reach and promise of CAR T-cells ...
Strategic Shift and Partnership Potential Drive Buy Rating for HOOKIPA Pharma
Roy Buchanan, an analyst from JMP Securities, reiterated the Buy rating on Hookipa Pharma (HOOK – Research Report). The associated price target ...